CRISPR Therapeutics advances with promising CTX310 data and key clinical milestones ahead. Click here to read an analysis of ...

Healthcare technology company Philips announced that it is investing more than $150 million in U.S. manufacturing and ...

Eli Lilly has signed a deal worth up to $1.3 billion with privately held Superluminal Medicines to discover and develop drugs ...

The US drugmaker Eli Lilly has bowed to demands from Donald Trump by raising the prices of its weight-loss jab for UK ...

Eli Lilly delivered above-consensus results in the second quarter, surpassing Wall Street’s revenue and non-GAAP profit ...

Clinicians should ask patients if they’re experiencing ‘diabetes device distress’ and help guide them through it.

By Nqobile Dludla and Siyanda Mthethwa JOHANNESBURG (Reuters) -Danish drugmaker Novo Nordisk introduced its weight-loss drug ...

Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...

Drugs to treat ADHD were linked to a reduced risk of suicidal behavior, substance misuse and criminality in the first research of its kind.

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...